X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
SUN PHARMA Announces Quarterly Results (1QFY19); Net Profit Up 446.1%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUN PHARMA Announces Quarterly Results (1QFY19); Net Profit Up 446.1%
Thu, 16 Aug

SUN PHARMA has announced its results for the quarter ended June 2018. Here is a detailed performance review of the same:

SUN PHARMA Quarterly Financials

No. of Mths
Qtr. Ending
3
Jun-17*
3
Mar-18*
3
Jun-18*
QoQ ChangeYoY Change
Net SalesRs m62,08869,77172,2423.5%16.4%
Other incomeRs m1,5203,0281,998-34.0%31.4%
TurnoverRs m63,60872,79974,2392.0%16.7%
ExpensesRs m51,13152,93656,1756.1%9.9%
Gross profitRs m1,45216,83516,067-4.6%1006.9%
DepreciationRs m3,4664,5524,016-11.8%15.9%
InterestRs m1,0941,5541,309-15.8%19.6%
Profit before taxRs m-1,58913,75612,739-7.4%
TaxRs m1,618-1,7671,6391.3%
Profit after taxRs m-3,20715,52311,101-28.5%
Gross profit margin%2.324.122.2
Effective tax rate%-101.8-12.812.9
Net profit margin%-5.021.315.0
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter grew 16.4% on a year-on-year (YoY) basis. The expenses were up by 9.9% YoY during the same period.
  • The company's operating profit increased by 1006.9% YoY during the quarter. Consequently, operating profit margins witnessed a growth and stood at 22.2% in 1QFY19 as against 2.3% in 1QFY18.
  • Depreciation charges and finance costs increased by 15.9% YoY and 19.6% YoY, respectively.
  • Other income increased by 31.4% YoY during the quarter.
  • Net profit for the quarter increased by 446.1% YoY. Net profit margins during the quarter increased from -5.0% in 1QFY18 to 15.0% in 1QFY19.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter grew 3.5% on a quarter-on-quarter (QoQ) basis. The expenses were up by 6.1% QoQ during the same period.
  • The company's operating profit declined by 4.6% QoQ during the quarter. Consequently, operating profit margins witnessed a decline and stood at 22.2% in 1QFY19 as against 24.1% in 4QFY18.
  • Net profit for the quarter declined by 28.5% QoQ, while net profit margins declined from 21.3% in 4QFY18 to 15.0% in 1QFY19.

To see how SUN PHARMA has performed over the last eight quarters, please visit here.

SUN PHARMA Share Price Performance

Over the last one year, SUN PHARMA share price has moved up from Rs 485.2 to Rs 615.5, registering a Gain of Rs 130.3 or around 26.9%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 14,813.1 (up 0.9%). Over the last one year it has moved up from 13,214.8 to 14,813.1, a gain of 1,598 points (up 12.1%).

Overall, the S&P BSE SENSEX is up 20.1% over the year.

Current Valuations

At the current price of Rs 615.5, the price to earnings (P/E) ratio of SUN PHARMA stands at 36.4 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 4.0 times.

Equitymaster requests your view! Post a comment on "SUN PHARMA Announces Quarterly Results (1QFY19); Net Profit Up 446.1%". Click here!

  

Related Views on News

SUN PHARMA Announces Quarterly Results (3QFY19); Net Profit Up 265.5% (Quarterly Result Update)

Feb 13, 2019 | Updated on Feb 13, 2019

For the quarter ended December 2018, SUN PHARMA has posted a net profit of Rs 15 bn (up 265.5% YoY). Sales on the other hand came in at Rs 77 bn (up 16.3% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

SUN PHARMA 2017-18 Annual Report Analysis (Annual Result Update)

Dec 20, 2018 | Updated on Dec 20, 2018

Here's an analysis of the annual report of SUN PHARMA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.

SUN PHARMA Announces Quarterly Results (2QFY19); Net Profit Down 110.7% (Quarterly Result Update)

Nov 14, 2018 | Updated on Nov 14, 2018

For the quarter ended September 2018, SUN PHARMA has posted a net profit of Rs 1 bn (down 110.7% YoY). Sales on the other hand came in at Rs 69 bn (up 4.3% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

More Views on News

Most Popular

My Top 3 Defence Stocks to Buy Now(The 5 Minute Wrapup)

Mar 19, 2019

The urgency to privatise India's defence sector to make India self-reliant was never as strong as it is today.

5 Fundamentally Strong Stocks to Pick for Trading Today(Profit Hunter)

Mar 15, 2019

5 fundamentally strong stocks one could buy to trade in this market right now. Make sure you grab the chance this strongly rallying market offers.

This Small Cap Stock Could Offer Triple Digit Gains from its Current Price(Profit Hunter)

Mar 19, 2019

If you are still waiting for signals, remember, there is no correct timing, only right time to Buy stocks. For select small caps, that time is now.

Elections Don't Matter!(The Honest Truth)

Mar 13, 2019

Ajit Dayal shows us why from the point of view of the Indian economy, elections don't matter.

Two Growth Stocks that Doubled in a Little Over 12 Months!(The 5 Minute Wrapup)

Mar 13, 2019

The elements that fueled profit growth for these two companies led to a surge in their stock prices.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

SUN PHARMA SHARE PRICE


Mar 22, 2019 (Close)

TRACK SUN PHARMA

  • Track your investment in SUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SUN PHARMA 8-QTR ANALYSIS

COMPARE SUN PHARMA WITH

MARKET STATS